Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated With Estrogen Receptor-Negative Subtypes and Poor Prognosis

Hao Tang, Salwa Sebti, Rossella Titone, Yunyun Zhou, Ciro Isidoro, Theodora S. Ross, Hanina Hibshoosh, Guanghua Xiao, Milton Packer, Yang Xie, Beth Levine

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Both BRCA1 and Beclin 1 (BECN1) are tumor suppressor genes, which are in close proximity on the human chromosome 17q21 breast cancer tumor susceptibility locus and are often concurrently deleted. However, their importance in sporadic human breast cancer is not known. To interrogate the effects of BECN1 and BRCA1 in breast cancer, we studied their mRNA expression patterns in breast cancer patients from two large datasets: The Cancer Genome Atlas (TCGA) (n. = 1067) and the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) (n. = 1992). In both datasets, low expression of BECN1 was more common in HER2-enriched and basal-like (mostly triple-negative) breast cancers compared to luminal A/B intrinsic tumor subtypes, and was also strongly associated with TP53 mutations and advanced tumor grade. In contrast, there was no significant association between low BRCA1 expression and HER2-enriched or basal-like subtypes, TP53 mutations or tumor grade. In addition, low expression of BECN1 (but not low BRCA1) was associated with poor prognosis, and BECN1 (but not BRCA1) expression was an independent predictor of survival. These findings suggest that decreased mRNA expression of the autophagy gene BECN1 may contribute to the pathogenesis and progression of HER2-enriched, basal-like, and TP53 mutant breast cancers.

Original languageEnglish (US)
Pages (from-to)255-263
Number of pages9
JournalEBioMedicine
Volume2
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Estrogen Receptors
Tumors
Breast Neoplasms
Messenger RNA
Genes
Neoplasms
Taxonomies
Chromosomes
Triple Negative Breast Neoplasms
Mutation
Atlases
Autophagy
Human Chromosomes
Beclin-1
Tumor Suppressor Genes
Genome
Gene Expression
Survival

Keywords

  • Autophagy
  • BECN1
  • BRCA1
  • Breast cancer

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated With Estrogen Receptor-Negative Subtypes and Poor Prognosis. / Tang, Hao; Sebti, Salwa; Titone, Rossella; Zhou, Yunyun; Isidoro, Ciro; Ross, Theodora S.; Hibshoosh, Hanina; Xiao, Guanghua; Packer, Milton; Xie, Yang; Levine, Beth.

In: EBioMedicine, Vol. 2, No. 3, 01.03.2015, p. 255-263.

Research output: Contribution to journalArticle

Tang, Hao ; Sebti, Salwa ; Titone, Rossella ; Zhou, Yunyun ; Isidoro, Ciro ; Ross, Theodora S. ; Hibshoosh, Hanina ; Xiao, Guanghua ; Packer, Milton ; Xie, Yang ; Levine, Beth. / Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated With Estrogen Receptor-Negative Subtypes and Poor Prognosis. In: EBioMedicine. 2015 ; Vol. 2, No. 3. pp. 255-263.
@article{849a5f9913fc43d6b157296778fb7f9c,
title = "Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated With Estrogen Receptor-Negative Subtypes and Poor Prognosis",
abstract = "Both BRCA1 and Beclin 1 (BECN1) are tumor suppressor genes, which are in close proximity on the human chromosome 17q21 breast cancer tumor susceptibility locus and are often concurrently deleted. However, their importance in sporadic human breast cancer is not known. To interrogate the effects of BECN1 and BRCA1 in breast cancer, we studied their mRNA expression patterns in breast cancer patients from two large datasets: The Cancer Genome Atlas (TCGA) (n. = 1067) and the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) (n. = 1992). In both datasets, low expression of BECN1 was more common in HER2-enriched and basal-like (mostly triple-negative) breast cancers compared to luminal A/B intrinsic tumor subtypes, and was also strongly associated with TP53 mutations and advanced tumor grade. In contrast, there was no significant association between low BRCA1 expression and HER2-enriched or basal-like subtypes, TP53 mutations or tumor grade. In addition, low expression of BECN1 (but not low BRCA1) was associated with poor prognosis, and BECN1 (but not BRCA1) expression was an independent predictor of survival. These findings suggest that decreased mRNA expression of the autophagy gene BECN1 may contribute to the pathogenesis and progression of HER2-enriched, basal-like, and TP53 mutant breast cancers.",
keywords = "Autophagy, BECN1, BRCA1, Breast cancer",
author = "Hao Tang and Salwa Sebti and Rossella Titone and Yunyun Zhou and Ciro Isidoro and Ross, {Theodora S.} and Hanina Hibshoosh and Guanghua Xiao and Milton Packer and Yang Xie and Beth Levine",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.ebiom.2015.01.008",
language = "English (US)",
volume = "2",
pages = "255--263",
journal = "EBioMedicine",
issn = "2352-3964",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated With Estrogen Receptor-Negative Subtypes and Poor Prognosis

AU - Tang, Hao

AU - Sebti, Salwa

AU - Titone, Rossella

AU - Zhou, Yunyun

AU - Isidoro, Ciro

AU - Ross, Theodora S.

AU - Hibshoosh, Hanina

AU - Xiao, Guanghua

AU - Packer, Milton

AU - Xie, Yang

AU - Levine, Beth

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Both BRCA1 and Beclin 1 (BECN1) are tumor suppressor genes, which are in close proximity on the human chromosome 17q21 breast cancer tumor susceptibility locus and are often concurrently deleted. However, their importance in sporadic human breast cancer is not known. To interrogate the effects of BECN1 and BRCA1 in breast cancer, we studied their mRNA expression patterns in breast cancer patients from two large datasets: The Cancer Genome Atlas (TCGA) (n. = 1067) and the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) (n. = 1992). In both datasets, low expression of BECN1 was more common in HER2-enriched and basal-like (mostly triple-negative) breast cancers compared to luminal A/B intrinsic tumor subtypes, and was also strongly associated with TP53 mutations and advanced tumor grade. In contrast, there was no significant association between low BRCA1 expression and HER2-enriched or basal-like subtypes, TP53 mutations or tumor grade. In addition, low expression of BECN1 (but not low BRCA1) was associated with poor prognosis, and BECN1 (but not BRCA1) expression was an independent predictor of survival. These findings suggest that decreased mRNA expression of the autophagy gene BECN1 may contribute to the pathogenesis and progression of HER2-enriched, basal-like, and TP53 mutant breast cancers.

AB - Both BRCA1 and Beclin 1 (BECN1) are tumor suppressor genes, which are in close proximity on the human chromosome 17q21 breast cancer tumor susceptibility locus and are often concurrently deleted. However, their importance in sporadic human breast cancer is not known. To interrogate the effects of BECN1 and BRCA1 in breast cancer, we studied their mRNA expression patterns in breast cancer patients from two large datasets: The Cancer Genome Atlas (TCGA) (n. = 1067) and the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) (n. = 1992). In both datasets, low expression of BECN1 was more common in HER2-enriched and basal-like (mostly triple-negative) breast cancers compared to luminal A/B intrinsic tumor subtypes, and was also strongly associated with TP53 mutations and advanced tumor grade. In contrast, there was no significant association between low BRCA1 expression and HER2-enriched or basal-like subtypes, TP53 mutations or tumor grade. In addition, low expression of BECN1 (but not low BRCA1) was associated with poor prognosis, and BECN1 (but not BRCA1) expression was an independent predictor of survival. These findings suggest that decreased mRNA expression of the autophagy gene BECN1 may contribute to the pathogenesis and progression of HER2-enriched, basal-like, and TP53 mutant breast cancers.

KW - Autophagy

KW - BECN1

KW - BRCA1

KW - Breast cancer

UR - http://www.scopus.com/inward/record.url?scp=84924300470&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924300470&partnerID=8YFLogxK

U2 - 10.1016/j.ebiom.2015.01.008

DO - 10.1016/j.ebiom.2015.01.008

M3 - Article

C2 - 25825707

AN - SCOPUS:84924300470

VL - 2

SP - 255

EP - 263

JO - EBioMedicine

JF - EBioMedicine

SN - 2352-3964

IS - 3

ER -